|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
Q2 FY2024
As of Sep 30, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
Q2 FY2023
As of Sep 30, 2022
|
Q1 FY2023
As of Jun 30, 2022
|
Q4 FY2022
As of Mar 31, 2022
|
Q3 FY2022
As of Dec 31, 2021
|
Q2 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Gross loans receivable | ||||||||||||||||||||
| Less: | ||||||||||||||||||||
| Unearned interest, insurance and fees | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Loans receivable, net | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Operating lease right‐of‐use assets, net | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES & SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Senior notes payable | ||||||||||||||||||||
| Credit facility | ||||||||||||||||||||
| Revolving Credit Facility | ||||||||||||||||||||
| Warehouse Facility | ||||||||||||||||||||
| Total credit facility | ||||||||||||||||||||
| Senior unsecured notes payable, net | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Deferred revenue (contract liability) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||||
| Preferred stock, no par value Authorized 5,000,000, no shares issued or outstanding | ||||||||||||||||||||
| Common stock, no par value Authorized 95,000,000 shares; issued and outstanding 4,658,837 and 4,656,505 shares at June 30, 2026 and March 31, 2026, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
